My watch list
my.bionity.com  
Login  

8,333 Current news from the industry pharma

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

Kick-off meeting for the Human Brain Proteome Project

22-May-2003

The kick-off meeting of the Human Brain Proteome Project (HBPP) took place in Frankfurt on Monday, 28th of April 2003, under the patronage of the Human Proteome Organisation (HUPO) and the Deutsche Gesellschaft für Proteomforschung (DGPF). The HBPP initiative is coordinated by Prof. Dr. Helmut E. ...

more

Tecan launches the HS 400 - a compact 4-slide Hybridization Station

21-May-2003

Tecan, a leading player in the Life Sciences supply industry, today announced the launch of the HS 400 Hybridization Station, a compact version of Tecan's HS 4800 system launched last year. Designed for researchers who need to carry out a modest number of experiments per run, the fully automated ...

more

First positive phase III results with an anti-angiogenic therapy for cancer

Phase III trial of Avastin plus chemotherapy markedly extends survival of metastatic colorectal cancer patients

20-May-2003

Genentech, Inc. (NYSE: DNA) today announced that a Phase III study of Avastin(TM) (bevacizumab, rhuMAb-VEGF) plus chemotherapy in previously-untreated metastatic colorectal cancer patients met its primary endpoint of improving overall survival. The magnitude of the benefit observed far exceeded ...

more

Silicon Genetics Introduces BioScript Library

15-May-2003

Silicon Genetics today released the BioScript Library for use with its GeneSpring® and GeNetTM software solutions. This collection of over 40 scripts delivers a powerful tool set for automating the most common analytical projects challenging functional genomics labs today. The BioScript Library ...

more

Epimmune and Anosys announce merger agreement

14-May-2003

Epimmune Inc. and Anosys Inc. today announced that they have entered into a definitive merger agreement under which Epimmune will merge with privately-held Anosys in a strategic transaction that will create a combined company focused on the field of immunotherapeutics and products for the ...

more

Barr launches generic Accutane(R) capsules product

13-May-2003

Barr Laboratories, Inc. today announced that it has launched its AB-rated generic equivalent version of Roche Pharmaceutical's Accutane(R) Capsules, 10 mg, 20 mg and 40 mg, under the trademark name Claravis(TM) (Isotretinoin Capsules, USP). The U.S. Food & Drug Administration (FDA) approved the ...

more

Dendreon utilizes pervasive antigen telomerase in new cancer immunotherapy

Preclinical results show significant survival benefit

12-May-2003

Dendreon Corporation today announced it will present research highlighting the application of the company's new immunotherapy technology to the widely expressed cancer antigen, telomerase. Results of preclinical animal studies have demonstrated that the approach is capable of inducing tumor ...

more

InterBioScreen and Princeton BioMolecular Research enter into enhanced partnership to expand small molecule discovery chemistry

08-May-2003

InterBioScreen and Princeton BioMolecular Research announced a partnership which will build on their existing capabilities to produce and deliver new generations of discovery molecules for life science research, worldwide. The two companies signed a long-term collaborative agreement to exploit ...

more

Innogenetics announces positive results in pivotal preclinical study in sepsis

07-May-2003

Innogenetics today reported the results of its pivotal preclinical evaluation of a proprietary anti-inflammatory monoclonal antibody, INNO 202, for the treatment of severe sepsis. The very positive results achieved in a clinically relevant animal model open the prospects for clinical trials in ...

more

Analysis of R&D portfolio management

Portfolio management carves niche for itself in resource-constrained pharmaceutical market

02-May-2003

At the core of portfolio management lies the need to identify and prioritise the most profitable products/projects in the R&D pipeline with the aim of maximising return on investment. For the pharmaceutical industry, the difficulty of quantifying the uncertainties associated with product ...

more

Page 824 From 834
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE